Study of Efficacy and Safety of MEXIDOL®

Completed

Phase 3 Results N/A

Summary of Purpose

A multicenter, prospective, randomized, double-blind, placebo-controlled, parallel group study in patients with stroke

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 3 June 2016.

1 Oct 2014 31 May 2016 1 May 2016 Unavailable 1 Jun 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available